122 related articles for article (PubMed ID: 10670214)
1. [Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
Rogolino A; Farsi A; Brunelli T; Ilari I; Capanni M; Domeneghetti MP; Dorigo W; Lombardi R; Pulli R; Pratesi C; Gensini GF
Minerva Cardioangiol; 1999 Dec; 47(12):583. PubMed ID: 10670214
[No Abstract] [Full Text] [Related]
2. [Cardiopulmonary baroreceptors activity and skin microcirculation in patients with peripheral obliterative arteriopathy].
De Marchi S; Zannoni M; Prior M; Lucchese L; Arosio E; Lechi A
Minerva Cardioangiol; 1999 Dec; 47(12):586-8. PubMed ID: 10670216
[No Abstract] [Full Text] [Related]
3. [Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].
Mangiafico RA; Malatino LS; Attinà T; Dell'Arte S; Messina R
Minerva Cardioangiol; 1999 Dec; 47(12):652-3. PubMed ID: 10670246
[No Abstract] [Full Text] [Related]
4. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
Asfar S; Safar HA
J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
[TBL] [Abstract][Full Text] [Related]
5. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
6. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
[TBL] [Abstract][Full Text] [Related]
7. [Arterial pressure in the toes of patients with obliterative arteriopathy of the legs].
Di Nardo E; Spigonardo F; Kester G; Hinkley J; Romolo M; Iapadre P; Zecchini F; Possati F
Ann Ital Chir; 1984; 56(1):81-6. PubMed ID: 6476657
[No Abstract] [Full Text] [Related]
8. Effects of leg and body position on transcutaneous oxygen measurements in healthy subjects and subjects with peripheral artery disease after lower-extremity arterial revascularization: a pilot study.
Rich K
J Vasc Nurs; 2002 Dec; 20(4):125-35; quiz 136-7. PubMed ID: 12469073
[TBL] [Abstract][Full Text] [Related]
9. [Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].
Falcón CR; Carreras LO
Sangre (Barc); 1998 Feb; 43(1):47-54. PubMed ID: 9577181
[No Abstract] [Full Text] [Related]
10. Leucocyte-endothelial interactions in chronic critical limb ischaemia.
Ciuffetti G; Lombardini R; Pasqualini L; Vaudo G
Ann Ital Med Int; 1996; 11(3):170-4. PubMed ID: 8950845
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
di Giovanna VN
Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
[No Abstract] [Full Text] [Related]
12. [Atherogenic risk factors in patients with obliterative arteriopathy of the legs].
Scannapieco G; Parisi R; Bortoluzzi C; Doria S; Puato M; Ambrosio GB
Minerva Cardioangiol; 1999 Dec; 47(12):579-80. PubMed ID: 10670212
[No Abstract] [Full Text] [Related]
13. Homocysteine in myointimal hyperplasia.
Hansrani M; Gillespie JI; Stansby G
Eur J Vasc Endovasc Surg; 2002 Jan; 23(1):3-10. PubMed ID: 11748941
[TBL] [Abstract][Full Text] [Related]
14. [Obliterative arteriopathy of the legs associated with a vasculopathy of the supra-aortic trunk].
Bolognini G; Iezzi BG
Minerva Cardioangiol; 1985 Dec; 33(12):855-7. PubMed ID: 3912680
[No Abstract] [Full Text] [Related]
15. [Leukocyte rheology and controlled ischemia in peripheral obliterative vascular diseases].
Ciuffetti G; Mannarino E; Lombardini R; Pasqualini L; Scarponi AM; Palazzetti D; Mercuri M; Lupattelli G
Ric Clin Lab; 1989; 19 Suppl 1():95-7. PubMed ID: 2629096
[No Abstract] [Full Text] [Related]
16. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
Edvinsson LI; Edvinsson ML; Angus Deveber G
Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
[TBL] [Abstract][Full Text] [Related]
17. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
[TBL] [Abstract][Full Text] [Related]
18. Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy.
Ferlito S; Gallina M; Catassi S; Bisicchia A; Di Salvo MM
Panminerva Med; 1999 Dec; 41(4):307-9. PubMed ID: 10705710
[TBL] [Abstract][Full Text] [Related]
19. Sustained elevation of circulating vascular endothelial growth factor after percutaneous angioplasty for peripheral arterial diseases.
Liu TJ; Lai HC; Ting CT; Lee WL
Int J Cardiol; 2006 Mar; 107(3):415-6. PubMed ID: 16503265
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic physical exercise in the preoperative preparation of patients with obliterative vascular diseases of the legs].
Kulikov IuA; Dzhuraeva LA; Avazmatova KhR; Ismailova DA
Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):53-5. PubMed ID: 2711639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
